权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

PA-20-072: Accelerating the Use of Evidence-based Innovation in Healthcare Systems

PA-20-072：加速在医疗保健系统中使用循证创新

基本信息

批准号：
10175163
负责人：
ELLEN R. MEARA
金额：
$ 239.67万
依托单位：
DARTMOUTH COLLEGE
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-12-01 至 2022-11-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10175163
关键词：
PA 20 072 Accelerating Use

项目摘要

Project Summary This proposal aims to help accelerate the transition to a higher performing healthcare system by studying important clinical conditions to advance our understanding of the factors that influence the implementation of innovations – evidence-based and less so – in healthcare. The research extends collaborations between Dartmouth, the University of California at Berkeley, Harvard, and the High Value Healthcare Collaborative. The findings will help guide the development and use of evidence from patient-centered outcomes research. The research is rooted in three frameworks. First, we recognize the key role of four major factors that influence the implementation of innovations: the external environment (e.g., state policies), the characteristics of the organizations adopting the innovation (e.g., degree of integration), the internal organizational processes selected to implement the innovations (e.g., physician payment), and the characteristics of the innovation itself. Second, we acknowledge the diversity of innovations; the relative importance of different factors that influence adoption may vary across the key decision-makers involved: biomedical innovations target diseases and are generally adopted by physicians; care delivery innovations target patient groups defined by function or illness severity and are largely adopted by managers; patient engagement innovations focus on changing patient roles. Third, different types of organizations may be more or less able to respond to external influences or adopt different internal processes to improve care. The approach builds on these frameworks to study the use of innovations and their impact on health, health care and costs. The Data Core will conduct a National Survey of Healthcare Organizations and Systems and will identify, track and characterize health systems, and measure their performance through national and clinically enriched databases. Project One will evaluate how environmental factors influence clinical integration, adoption of new payment models, and how organizations use evidence. Project Two will evaluate the internal mechanisms that health systems use to increase clinicians’ adoption of evidence-based practices and how and why systems adopt these approaches. Project Three will study the factors that influence the use of more or less effective biomedical innovations. Project Four will study the factors that influence the use of care delivery innovations and how the implementation of these innovations can be improved. Project Five examines the environmental and organizational factors associated with the use of interventions to enhance patient engagement and measure patient-centered outcomes of care.

项目摘要该提案旨在通过研究帮助加速向更高性能的医疗保健系统过渡，重要的临床条件，以促进我们对影响实施的因素的理解，医疗保健领域的创新--以证据为基础的创新和较少的创新。这项研究扩展了达特茅斯、加州大学伯克利分校、哈佛和高价值医疗保健合作组织。的研究结果将有助于指导以患者为中心的结果研究证据的开发和使用。该研究基于三个框架。首先，我们认识到四个主要因素的关键作用，影响创新的实施：外部环境（例如，国家政策），特点采用创新的组织（例如，整合度），内部组织流程被选择来实现创新（例如，医生支付），以及创新本身的特点。第二，我们承认创新的多样性;不同因素的相对重要性，采用可能会因所涉及的关键决策者而异：生物医学创新针对疾病，一般由医生采用;护理提供创新的目标患者群体定义的功能或疾病严重性，并在很大程度上被管理人员采用;患者参与创新专注于改变患者角色第三，不同类型的组织可能或多或少能够应对外部影响，采用不同的内部流程来改善护理。该方法建立在这些框架的基础上，研究创新的使用及其对健康、健康和环境的影响。照顾和费用。该数据中心将对医疗保健组织和系统进行全国调查，确定、跟踪和描述卫生系统的特点，并通过国家和丰富的临床数据库。项目一将评估环境因素如何影响临床整合，采用新的支付模式，以及组织如何使用证据。项目二将评估卫生系统用于增加临床医生采用循证实践的内部机制以及系统如何以及为什么采用这些方法。项目三将研究影响使用的因素或多或少有效的生物医学创新。项目四将研究影响使用医疗服务创新以及如何改进这些创新的实施。项目五检查与使用干预措施相关的环境和组织因素，以增强患者参与度和衡量以患者为中心的护理结果。